Publisher
Springer International Publishing
Reference87 articles.
1. Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80(suppl):1588–94.
2. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 1997;69:1–18.
3. Hansen BH, Keller J, Laitinen M, et al. The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl. 2004;75:11–5.
4. Delea TE, McKiernan JM, Liss M, et al. Impact of skeletal complications on total medical care costs in lung cancer patients with bone metastases. Proc Am Soc Clin Oncol. 2004;23:533 [Abstract 6064].
5. Rosen LS, Gordon D, Tchekmedyian NS, et al. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non-small cell lung carcinoma and other solid tumors: a randomized, phase III, double-blind, placebo-controlled trial. Cancer. 2004;100:2613–21.